Alerta De Seguridad para Automated Endoscope Reprocessors

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Custom Ultrasonics.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2015-11-16
  • Fecha de publicación del evento
    2015-11-16
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: custom ultrasonics automated endoscope reprocessors the united states food and drug administration (fda) has issued an alert concerning all automated endoscope reprocessors manufactured by custom ultrasonics. in accordance with a consent decree entered in january 2007 with custom ultrasonics, the fda ordered custom ultrasonics to recall all of its automated endoscope reprocessors (aers) from health care facilities due to the firm’s continued violations of the federal food, drug, and cosmetic act (fd&c act), applicable regulations, and the consent decree. fda is recommending that health care facilities currently using custom ultrasonics aers transition away from their use to alternative methods to reprocess flexible endoscopes as soon as possible. as part of the fda’s ongoing investigation into infections associated with reprocessed medical devices and aer devices used for cleaning and disinfection, the fda has been reviewing the validation test methods and performance data for all aer manufacturers. to date, custom ultrasonics has not demonstrated that its aers can adequately wash and disinfect endoscopes to mitigate the risk of patient infection. the fda’s most recent inspection of the custom ultrasonics’ facility in april 2015 documented continued violations. violations include the inability to validate that the aers can adequately wash and disinfect endoscopes to mitigate the risk of patient infection. the identified violations could result in an increased risk of infection transmission. the fda recommends that health care facilities currently using custom ultrasonics aers transition away from their use to alternative reprocessing methods as soon as possible. facilities are advised to: identify and transition to alternate methods to reprocess flexible endoscopes, such as manual high-level disinfection, liquid chemical sterilization, alternative aers, or other cleaning and sterilization methods according to the endoscope manufacturers’ reprocessing instructions. before transitioning to an alternative method, be sure that the endoscopes used are compatible with the alternative method by referring to the endoscope manufacturer’s reprocessing instructions. for details, please refer to the fda websites:http://www.Fda.Gov/medicaldevices/safety/alertsandnotices/ucm472462.Htmhttp://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm472686.Htm posted on 16 november 2015.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Custom Ultrasonics Automated Endoscope Reprocessors
  • Manufacturer

Manufacturer